# 20/20 Biolabs Inc. (AIDX)

Source: https://www.quantisnow.com/company/AIDX
Generated: 2026-11-16T22:55:24.554Z

- Ticker: AIDX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Precision Instruments
- SEC CIK: 0001139685

## Latest AIDX news and filings

- 2026-11-16 21:39 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-results-of-operations-6794664)
- 2026-11-16 21:05 UTC [Earnings] [20/20 BioLabs Reports Third Quarter 2026 Financial Results and Recent Business Updates](https://www.quantisnow.com/insight/2020-biolabs-reports-third-quarter-2026-financial-results-and-recent-6793937)
- 2026-11-05 13:31 UTC [Conference Announcement] [REMINDER TO VOTE: 20/20 BioLabs Special Meeting of Stockholders to Be Held December 9, 2026](https://www.quantisnow.com/insight/reminder-to-vote-2020-biolabs-special-meeting-of-stockholders-to-6775028)
- 2026-10-29 13:37 UTC [Conference Announcement] [20/20 BioLabs to Host November 4 Investor Webinar on OneTest™ Commercial Expansion and Growth Strategy](https://www.quantisnow.com/insight/2020-biolabs-to-host-november-4-investor-webinar-on-onetest-6762980)
- 2026-10-21 20:12 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-2020-biolabs-inc-6753605)
- 2026-10-21 20:10 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-2020-biolabs-inc-6753594)
- 2026-10-06 20:33 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-2020-biolabs-inc-6739150)
- 2026-10-02 12:31 UTC [Conference Announcement] [20/20 BioLabs to Participate in the Maxim Growth Summit 2026 in New York on October 14, 2026](https://www.quantisnow.com/insight/2020-biolabs-to-participate-in-the-maxim-growth-summit-2026-6733545)
- 2026-09-29 12:31 UTC [Conference Announcement] [20/20 BioLabs to Host Investor Webinar on October 7, 2026 to Discuss FDA Advisory Committee Vote and New OneTest™ Franchise Model](https://www.quantisnow.com/insight/2020-biolabs-to-host-investor-webinar-on-october-7-2026-6728678)
- 2026-09-18 20:05 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-submission-of-matters-6720488)
- 2026-09-10 20:10 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-notice-of-delisting-6711625)
- 2026-09-02 20:32 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-regulation-fd-disclosure-6703437)
- 2026-08-28 22:26 UTC [Conference Announcement] [20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity](https://www.quantisnow.com/insight/2020-biolabs-reschedules-investor-webinar-to-200-pm-eastern-time-6698770)
- 2026-08-26 12:31 UTC [Conference Announcement] [20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity](https://www.quantisnow.com/insight/2020-biolabs-to-host-investor-webinar-on-september-2-2026-6695108)
- 2026-08-19 20:50 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-2020-biolabs-inc-6688684)
- 2026-08-19 13:19 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-submission-of-matters-6688011)
- 2026-08-17 20:14 UTC [SEC Form 424B3] [SEC Form 424B3 filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-2020-biolabs-inc-6685010)
- 2026-08-17 20:10 UTC [SEC Form 424B3] [SEC Form 424B3 filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-2020-biolabs-inc-6684975)
- 2026-08-17 20:05 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-results-of-operations-6684927)
- 2026-08-17 12:31 UTC [Conference Announcement] [20/20 BioLabs Reports Second Quarter 2026 Financial Results and Recent Operational Progress, as Cancer Test Revenue Reaches Record Quarterly Level](https://www.quantisnow.com/insight/2020-biolabs-reports-second-quarter-2026-financial-results-and-recent-6684457)
- 2026-08-05 16:00 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-regulation-fd-disclosure-6664543)
- 2026-07-30 12:31 UTC [Conference Announcement] [20/20 BioLabs to Host Investor Webinar on August 5, 2026, to Discuss Commercial Opportunities Following Management’s Recent East Asia Business Development Tour](https://www.quantisnow.com/insight/2020-biolabs-to-host-investor-webinar-on-august-5-2026-6655269)
- 2026-07-27 20:30 UTC [20/20 BioLabs Participates in BIO Asia-Taiwan and Meets with Strategic Counterparties in Taipei, Tokyo, and Seoul to Advance East Asia Roll-Up Strategy](https://www.quantisnow.com/insight/2020-biolabs-participates-in-bio-asia-taiwan-and-meets-with-strategic-6649961)
- 2026-07-23 12:31 UTC [20/20 BioLabs Announces Standstill Agreement with Streeterville Capital Regarding Series E Convertible Preferred Stock](https://www.quantisnow.com/insight/2020-biolabs-announces-standstill-agreement-with-streeterville-capital-regarding-series-6646462)
- 2026-07-22 20:45 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-entry-into-a-6645591)
- 2026-07-09 20:01 UTC [Conference Announcement] [20/20 BioLabs Highlights Investor Webinar Focused on OneTest™ for Medicare, Serial Biomarker Tracking, and Strong Q2 Revenue Growth](https://www.quantisnow.com/insight/2020-biolabs-highlights-investor-webinar-focused-on-onetest-for-medicare-6632911)
- 2026-07-01 19:28 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-regulation-fd-disclosure-6622639)
- 2026-06-23 21:02 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-2020-biolabs-inc-6612962)
- 2026-06-23 21:02 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-2020-biolabs-inc-6612960)
- 2026-06-22 20:45 UTC [Conference Announcement] [20/20 BioLabs Announces Monthly Investor Webinar Series to be Held on the First Wednesday of Each Month](https://www.quantisnow.com/insight/2020-biolabs-announces-monthly-investor-webinar-series-to-be-held-6611495)
- 2026-06-01 20:40 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-2020-biolabs-inc-6582101)
- 2026-05-27 12:31 UTC [20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters](https://www.quantisnow.com/insight/2020-biolabs-multi-cancer-early-detection-blood-test-selected-by-state-6574006)
- 2026-05-26 20:28 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-material-modification-to-6572518)
- 2026-05-22 12:31 UTC [20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand](https://www.quantisnow.com/insight/2020-biolabs-commences-emergency-planning-for-ebola-hantavirus-lab-testing-6568955)
- 2026-05-21 20:11 UTC [SEC Form 424B3] [SEC Form 424B3 filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-2020-biolabs-inc-6567413)
- 2026-05-21 20:09 UTC [SEC Form 424B3] [SEC Form 424B3 filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-2020-biolabs-inc-6567379)
- 2026-05-20 20:18 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by 20/20 Biolabs Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-2020-biolabs-inc-6565275)
- 2026-05-20 20:10 UTC [SEC Form 8-K] [20/20 Biolabs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/2020-biolabs-inc-filed-sec-form-8-k-results-of-operations-6565109)
- 2026-05-20 20:05 UTC [Dividends] [20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress](https://www.quantisnow.com/insight/2020-biolabs-reports-first-quarter-2026-financial-results-and-recent-6564962)
- 2026-05-20 11:30 UTC [Market Insight] [Sidoti Events, LLC's May Micro-Cap Virtual Conference](https://www.quantisnow.com/insight/sidoti-events-llcs-may-micro-cap-virtual-conference-6564285)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/AIDX
- Earnings history: https://www.quantisnow.com/earnings/AIDX
- Dividend history: https://www.quantisnow.com/dividends/AIDX
- Insider transactions: https://www.quantisnow.com/insiders/AIDX
- Options chain: https://www.quantisnow.com/options/AIDX
- SEC 8-K filings only: https://www.quantisnow.com/company/AIDX/8-k
- RSS and alerts for AIDX: https://www.quantisnow.com/docs/rss-feeds.md
